Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Treatment with interferon beta-1a plus the antiviral remdesivir was not superior to remdesivir alone.
Collins has led the NIH under three presidents over more than 12 years.
The NIH awarded nearly $470 million to build a national study population of diverse research volunteers.
About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.
Trial also will test pausing immunosuppressive medication to improve antibody response.
Coronavirus transmission via fomites is markedly less efficient than airborne transmission but does occur.
The findings underscore the need for policies to expand vaccine administration, especially for low-income and minority populations.
Health officials are preparing to offer booster shots for all adults starting eight months after the second dose.
Trial will assess antibody response in people who did not respond to two-dose regimen.
Rapid test results are needed to interrupt the chain of coronavirus transmission.
Mobile clinics could be innovative strategy for expanding access to care and providing uninterrupted treatment for people who inject drugs.
The trial will inform public health policy on the potential use of mixed vaccine schedules if booster doses are needed.
Research suggests how to develop more broadly effective therapies and vaccines.
Researchers used an airway-on-a-chip that mimics living lung tissue to screen approved drugs for use against SARS-CoV-2.
Cancer, diabetes and Alzheimer’s would be the initial focus for the proposed agency within the National Institutes of Health.
People with long COVID have diverse clinical conditions that will require individualized and multidisciplinary approaches to treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.